A phase I study of the GM-CSF antagonist E21R

I Olver; T Hercus; A Lopez; M Vadas; A Somogyi; Ian Doyle; D Foster; D Keefe; A Taylor; M Brown; L To; J Cole; T Rawling; null Cambareri; M Myers; N Olszewski; S Bastiras; C Senn; A Hey; M Verma; P Wigley

A phase I study of the GM-CSF antagonist E21R

I Olver, T Hercus, A Lopez, M Vadas, A Somogyi, Ian Doyle, D Foster, D Keefe, A Taylor, M Brown, L To, J Cole, T Rawling, Cambareri, M Myers, N Olszewski, S Bastiras, C Senn, A Hey, M VermaP Wigley

Research output: Contribution to journal › Article › peer-review

8 Citations (Scopus)

Original language	English
Pages (from-to)	171-178
Number of pages	8
Journal	Cancer Chemotherapy and Pharmacology
Volume	50
Issue number	3
Publication status	Published - 2002

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{2199d42061a54b2f892105f1e1f2e4e2,

title = "A phase I study of the GM-CSF antagonist E21R",

author = "I Olver and T Hercus and A Lopez and M Vadas and A Somogyi and Ian Doyle and D Foster and D Keefe and A Taylor and M Brown and L To and J Cole and T Rawling and Cambareri and M Myers and N Olszewski and S Bastiras and C Senn and A Hey and M Verma and P Wigley",

year = "2002",

language = "English",

volume = "50",

pages = "171--178",

journal = "Cancer Chemotherapy and Pharmacology",

issn = "0344-5704",

publisher = "Springer-Verlag",

number = "3",

}

TY - JOUR

T1 - A phase I study of the GM-CSF antagonist E21R

AU - Olver, I

AU - Hercus, T

AU - Lopez, A

AU - Vadas, M

AU - Somogyi, A

AU - Doyle, Ian

AU - Foster, D

AU - Keefe, D

AU - Taylor, A

AU - Brown, M

AU - To, L

AU - Cole, J

AU - Rawling, T

AU - Cambareri, null

AU - Myers, M

AU - Olszewski, N

AU - Bastiras, S

AU - Senn, C

AU - Hey, A

AU - Verma, M

AU - Wigley, P

PY - 2002

Y1 - 2002

M3 - Article

SN - 0344-5704

VL - 50

SP - 171

EP - 178

JO - Cancer Chemotherapy and Pharmacology

JF - Cancer Chemotherapy and Pharmacology

IS - 3

ER -